Water Cooler Chat Session: COVID-19 Impact on Clinical Supply Chains | Recorded May 27, 2020

COVID-19 has decreased the number of available transportation routes and presented distribution challenges. This has added a level of complexity to supplying clinical trials domestically and internationally. In this chat, PCI’s Distribution Manager Thomas Johnson will share his observations on how COVID-19 has impacted clinical supply chains. We will also have a special guest David Spillett, Global Accounts Director from World Courier to share his observations.
This chat will specifically focus on how COVID-19 has impacted:

  • Domestic and international distribution trends
  • Availability of active and passive packing systems
  • Availability of transportation lanes

Just-In-Time clinical studies

Listen to the audio here: COVID-19 Impact on Clinical Supply Chains (mp3)

We provide a complete range of clinical trial services and we are committed to supporting clients at every stage of the clinical cycle, delivering best-in-class services efficiently and effectively.

Find out more about our clinical trial services.

Our dedicated team of specialists will be happy to discuss any of your clinical trial service needs. Contact us on +1 779-208-1819 (US) or +44 1495 711 222 (UK/EU) or email talkfuture@pci.com